Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.50% | -18.13% | -25.10% | -22.80% | -14.22% |
| Total Receivables | 100.08% | 94.82% | 125.89% | 114.03% | -20.35% |
| Inventory | 33.89% | 23.93% | 88.60% | 39.68% | 22.99% |
| Prepaid Expenses | 18.70% | 84.65% | 43.44% | 42.07% | 0.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -87.99% | -83.76% | -80.50% | -- |
| Total Current Assets | -2.87% | -8.00% | -12.28% | -13.79% | -14.28% |
|
|
|||||
| Total Current Assets | -2.87% | -8.00% | -12.28% | -13.79% | -14.28% |
| Net Property, Plant & Equipment | 99.55% | 24.70% | 6.31% | 11.10% | 6.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -22.91% | -33.95% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -54.02% | 23.91% | 39.51% | 12.13% | 20.85% |
| Total Assets | 3.80% | -1.32% | -6.02% | -8.98% | -9.65% |
|
|
|||||
| Total Accounts Payable | 115.03% | 280.79% | 90.84% | 47.25% | 25.92% |
| Total Accrued Expenses | 90.70% | -- | -- | -47.67% | 4.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6,702.08% | 3,360.32% | 77.62% | 71.41% | 51.18% |
| Total Finance Division Other Current Liabilities | -38.81% | 83.76% | 54.82% | 17.07% | 40.32% |
| Total Other Current Liabilities | -38.81% | 83.76% | 54.82% | 17.07% | 40.32% |
| Total Current Liabilities | 129.17% | 60.05% | -9.79% | -6.13% | 28.32% |
|
|
|||||
| Total Current Liabilities | 129.17% | 60.05% | -9.79% | -6.13% | 28.32% |
| Long-Term Debt | -- | -42.04% | 6.42% | 6.76% | 7.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 95.52% | 93.01% | 62.89% | 14.50% | 0.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.15% | 23.57% | -25.77% | -79.67% | -88.97% |
| Total Liabilities | 16.20% | 13.23% | 2.38% | -2.15% | 5.42% |
|
|
|||||
| Common Stock & APIC | 2.01% | 1.96% | 2.21% | 2.53% | 2.24% |
| Retained Earnings | -17.86% | -14.20% | -20.82% | -14.12% | -11.92% |
| Treasury Stock & Other | 3,290.32% | 69.50% | 307.20% | 7.76% | -93.73% |
| Total Common Equity | -3.70% | -9.39% | -10.65% | -12.57% | -16.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.70% | -9.39% | -10.65% | -12.57% | -16.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.70% | -9.39% | -10.65% | -12.57% | -16.84% |
|
|
|||||